DelveInsight’s “Colorectal cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market size of the Colorectal Cancer (CRC) for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes global historical and forecasted epidemiological data for the diagnosed cases of Colorectal Cancer (CRC) from 2013-2023. According to DelveInsight, the 7MM Diagnosed cases for Colorectal Cancer are expected to increase, with total 514,148 cases in 2023.
According to DelveInsight, the 7 MM market size of Colorectal Cancer market is estimated to be USD 11682 million by 2023.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Key Coverage and Benefits:
• The report will help in developing business strategies by understanding the trends shaping and driving the global Colorectal Cancer market.
• Organize sales and marketing efforts by identifying the best opportunities for Colorectal Cancer in US, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan.
• To understand the future market competition in the global Colorectal Cancer market and Insightful review of the key market drivers and barriers.
• The Report also covers the detailed global historical and forecasted Colorectal Cancer market covering United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides market size of Colorectal Cancer for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Report Introduction
Colorectal Cancer Market Overview at a Glance
Global Market Size of Colorectal Cancer (2013-2023)
7 MM Market Size of Colorectal Cancer (2013-2023)
Total Market Share Distribution of Colorectal Cancer for 7 MM in 2016
Total Market Share Distribution of Colorectal Cancer for 7 MM in 2023
Colorectal Cancer
Overview
Stages
Pathophysiology
Etiology
Risk Factors
Diagnosis
Treatment
Epidemiology and Patient Population
Total number of cases – 7MM Countries – (2016 & 2023)
United States
Diagnosed Cases of Colorectal Cancer in United States
Diagnosed Cases of Colorectal Cancer by Stages
Diagnosed Cases of Colorectal Cancer by Site
Germany
Diagnosed Cases of Colorectal Cancer in Germany
Diagnosed Cases of Colorectal Cancer by Stages
Diagnosed Cases of Colorectal Cancer by Site
France
Diagnosed Cases of Colorectal Cancer in France
Diagnosed Cases of Colorectal Cancer by Stages
Diagnosed Cases of Colorectal Cancer by Site
United Kingdom
Diagnosed Cases of Colorectal Cancer in United Kingdom
Diagnosed Cases of Colorectal Cancer by Stages
Diagnosed Cases of Colorectal Cancer by Site
Spain
Diagnosed Cases of Colorectal Cancer in Spain
Diagnosed Cases of Colorectal Cancer by Stages
Diagnosed Cases of Colorectal Cancer by Site
Italy
Diagnosed Cases of Colorectal Cancer in Italy
Diagnosed Cases of Colorectal Cancer by Stages
Diagnosed Cases of Colorectal Cancer by Site
Japan
Diagnosed Cases of Colorectal Cancer in Japan
Diagnosed Cases of Colorectal Cancer by Stages
Diagnosed Cases of Colorectal Cancer by Site
Treatment Algorithm
Current Unmet Needs
Marketed Drugs
Key Marketed Drugs
Avastin
Regulatory Milestones
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects
Erbitux
Regulatory Milestones
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects
Stivarga
Regulatory Milestones
Advantages & Disadvantages
Safety
Side effects
Xeloda
Regulatory Milestones
Advantages & Disadvantages
Efficacy
Safety
Side effects
Vectibix
Regulatory Milestones
Advantages & Disadvantages
Efficacy
Safety
Side effects
Emerging Therapies
Xilonix: XBiotech Inc.
Regulatory Milestones
Product Development Activities
Clinical Development
Product Profile
Clinical Pipeline Activity
Ongoing Trials Information
Clinical Trial by Phase
Famitinib: Jiangsu Hengrui Medicine Co.
Clinical Development
Product Profile
Clinical Pipeline Activity
Ongoing Trials Information
Clinical Trial by Phase
Nintedanib: Boehringer Ingelheim GmbH
Clinical Development
Product Profile
Clinical Pipeline Activity
Clinical Trial by Phase
Lefitolimod: Mologen AG.
Clinical Development
Product Profile
Clinical Pipeline Activity
Ongoing Trials Information
Clinical Trial by Phase
Napabucasin: Sumitomo Dainippon Pharma Co. Ltd.
Product Development Activities
Agreement
Acquisition
Clinical Development
Product Profile
Clinical Pipeline Activity
Ongoing Trials Information
Clinical Trial by Phase
Global Colorectal Cancer: Country-Wise Market Analysis
Overview on Total Colorectal Cancer Market (2016)
Overview on Total Colorectal Cancer Market (2023)
United States Market Size
Colorectal Cancer (CRC) Market Distribution by Stage (2016)
Europe Market Size
Germany Market Size
Colorectal Cancer (CRC) Market Distribution by Stage (2016)
France Market Size
Colorectal Cancer (CRC) Market Distribution by Stage (2016)
United Kingdom Market Size
Colorectal Cancer (CRC) Market Distribution by Stage (2016)
Spain Market Size
Colorectal Cancer (CRC) Market Distribution by Stage (2016)
Italy Market Size
Colorectal Cancer (CRC) Market Distribution by Stage (2016)
Japan Market Size
Colorectal Cancer (CRC) Market Distribution by Stage (2016)
Market Drivers
Market Barriers
Report Methodology
Consulting Services
Disclaimer
About DelveInsight
Table 1: Global Market Size of Colorectal Cancer in USD Million (2013-2023)
Table 2: 7 MM Market Size of Colorectal Cancer in USD Million (2013-2023)
Table 3: Diagnosed Cases of Colorectal Cancer in United States (2013-2023)
Table 4: Diagnosed Cases Colorectal Cancer by stages in United States (2016)
Table 5: Diagnosed Cases of Colorectal Cancer by site in United States (2016)
Table 6: Diagnosed Cases of Colorectal Cancer of Colorectal Cancer in Germany (2013-2023)
Table 7: Diagnosed Cases of Colorectal Cancer by Stages in Germany (2016)
Table 8: Diagnosed Cases of Colorectal Cancer by Site in Germany (2016)
Table 9: Diagnosed Cases Colorectal Cancer in France (2013-2023)
Table 10: Diagnosed Cases of Colorectal Cancer by Stages in France (2016)
Table 11: Diagnosed Cases of Colorectal Cancer by Site in France (2016)
Table 12: Diagnosed Cases of Colorectal Cancer in United Kingdom (2013-2023)
Table 13: Diagnosed Cases Colorectal Cancer by Stages in United Kingdom (2016)
Table 14: Diagnosed Cases of Colorectal Cancer by Site in United Kingdom (2016)
Table 15: Diagnosed Cases of Colorectal Cancer in Spain (2013-2023)
Table 16: Diagnosed Cases Colorectal Cancer by stages in Spain (2016)
Table 17: Diagnosed Cases Colorectal Cancer by Site in Spain (2016)
Table 18: Diagnosed Cases of Colorectal Cancer in Italy (2013-2023)
Table 19: Diagnosed Cases of Colorectal Cancer by Stages in Italy (2016)
Table 20: Diagnosed Cases of Colorectal Cancer by Site in Italy (2016)
Table 21: Diagnosed Cases of Colorectal Cancer in Japan (2013-2023)
Table 22: Diagnosed Cases of Colorectal Cancer by Stages in Japan (2016)
Table 23: Diagnosed Cases of Colorectal Cancer by Site in Japan (2016)
Table 24: List of Marketed Drugs for Colorectal Cancer
Table 25: Emerging Therapies for Colorectal Cancer
Table 26: Xilonix, Clinical Trials by Zone
Table 27: Clinical Trials by Recruitment status
Table 28: Famitinib, Clinical Trials by Zone
Table 29: Clinical Trials by Recruitment status, 2017
Table 30: Nintedanib, Clinical Trials by Zone
Table 31: Lefitolimod, Clinical Trials by Zone
Table 32: Clinical Trials by Recruitment status
Table 33: Napabucasin, Clinical Trials by Zone
Table 34: Clinical Trials by Recruitment status, 2017
Table 35: United States Market Size of Colorectal Cancer in USD, Million (2013-2023)
Table 36: United States Colorectal Cancer (CRC) Market Distribution by Stage (2016)
Table 37: Germany Market Size of Colorectal Cancer in USD, Million (2013-2023)
Table 38: Germany Colorectal Cancer (CRC) Market Distribution by Stage (2016)
Table 39: France Market Size of Colorectal Cancer in USD, Million (2013-2023)
Table 40: France Colorectal Cancer (CRC) Market Distribution by Stage (2016)
Table 41: United Kingdom Market Size of Colorectal Cancer in USD, Million (2013-2023)
Table 42: United Kingdom Colorectal Cancer (CRC) Market Distribution by Stage (2016)
Table 43: Spain Market Size of Colorectal Cancer in USD, Million (2013-2023)
Table 44: Spain Colorectal Cancer (CRC) Market Distribution by Stage (2016)
Table 45: Italy Market Size of Colorectal Cancer in USD, Million (2013-2023)
Table 46: Italy Colorectal Cancer (CRC) Market Distribution by Stage (2016)
Table 47: Japan Market Size of Colorectal Cancer in USD, Million (2013-2023)
Table 48: Japan Colorectal Cancer (CRC) Market Distribution by Stage (2016)
